Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules
- 31 December 2006
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (12) , 1709-1719
- https://doi.org/10.1016/j.exphem.2006.07.009
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemiaBlood, 2005
- The development of imatinib as a therapeutic agent for chronic myeloid leukemiaBlood, 2005
- RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myelomaBlood, 2004
- Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicityLeukemia, 2003
- CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemiaBlood, 2002
- Chronic Myelogenous LeukemiaHematology-American Society Hematology Education Program, 2002
- Simultaneous expression of different immunogenic antigens in acute myeloid leukemiaExperimental Hematology, 2000
- Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory ReceptorImmunity, 1997
- Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformationCell, 1995
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991